Pharmaceutical Manufacturing: Is It the Antithesis of Creative Destruction?

PAT and QbD can only move forward if the industry sheds its habit of QbA (i.e., quality by analysis)

By Girish Malhotra, PE, President, EPCOT International, Inc.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments